Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 10 | 2024 | 367 | 2.150 |
Why?
|
| Caenorhabditis elegans | 8 | 2024 | 146 | 1.340 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 216 | 0.970 |
Why?
|
| Molecular Dynamics Simulation | 4 | 2020 | 40 | 0.970 |
Why?
|
| Indans | 2 | 2020 | 9 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 176 | 0.820 |
Why?
|
| Thiadiazoles | 1 | 2020 | 15 | 0.770 |
Why?
|
| Ubiquitination | 1 | 2019 | 47 | 0.720 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 99 | 0.700 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 92 | 0.690 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2018 | 60 | 0.680 |
Why?
|
| Proteins | 2 | 2018 | 376 | 0.650 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 151 | 0.620 |
Why?
|
| Replication Origin | 1 | 2017 | 11 | 0.620 |
Why?
|
| Telomerase | 1 | 2017 | 30 | 0.620 |
Why?
|
| RNA, Transfer | 1 | 2017 | 25 | 0.610 |
Why?
|
| Signal Transduction | 4 | 2024 | 1753 | 0.610 |
Why?
|
| DNA Replication | 1 | 2017 | 152 | 0.570 |
Why?
|
| Molecular Docking Simulation | 6 | 2023 | 83 | 0.540 |
Why?
|
| DNA, Mitochondrial | 1 | 2017 | 186 | 0.540 |
Why?
|
| Neurodegenerative Diseases | 3 | 2022 | 83 | 0.470 |
Why?
|
| Antineoplastic Agents | 5 | 2021 | 1300 | 0.460 |
Why?
|
| Apolipoprotein E4 | 2 | 2024 | 19 | 0.400 |
Why?
|
| Lysosomes | 2 | 2024 | 91 | 0.380 |
Why?
|
| Models, Molecular | 4 | 2019 | 423 | 0.380 |
Why?
|
| Protein Conformation | 3 | 2020 | 226 | 0.380 |
Why?
|
| Ubiquitin | 3 | 2019 | 51 | 0.380 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 64 | 0.370 |
Why?
|
| Animals | 13 | 2024 | 14385 | 0.360 |
Why?
|
| Neoplasms | 1 | 2020 | 1316 | 0.350 |
Why?
|
| Autophagy | 2 | 2024 | 202 | 0.340 |
Why?
|
| Sesquiterpenes | 2 | 2021 | 91 | 0.340 |
Why?
|
| NF-kappa B | 2 | 2021 | 335 | 0.320 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 2018 | 15 | 0.310 |
Why?
|
| Mice | 4 | 2024 | 6413 | 0.280 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2018 | 131 | 0.280 |
Why?
|
| Protein Binding | 5 | 2018 | 736 | 0.270 |
Why?
|
| Humans | 23 | 2024 | 54284 | 0.270 |
Why?
|
| 14-3-3 Proteins | 2 | 2022 | 24 | 0.260 |
Why?
|
| Binding Sites | 3 | 2021 | 440 | 0.260 |
Why?
|
| Catalytic Domain | 2 | 2020 | 62 | 0.230 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2022 | 7 | 0.220 |
Why?
|
| Profilins | 2 | 2023 | 18 | 0.220 |
Why?
|
| Glioblastoma | 1 | 2024 | 99 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2020 | 96 | 0.210 |
Why?
|
| Apoptosis | 2 | 2020 | 1300 | 0.210 |
Why?
|
| Benzylamines | 1 | 2021 | 18 | 0.200 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 25 | 0.200 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2021 | 7 | 0.200 |
Why?
|
| Cell Line | 3 | 2020 | 1153 | 0.200 |
Why?
|
| Alkaloids | 1 | 2021 | 37 | 0.200 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 767 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2020 | 21 | 0.190 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 14 | 0.190 |
Why?
|
| HL-60 Cells | 1 | 2020 | 24 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2021 | 614 | 0.190 |
Why?
|
| Brain Neoplasms | 1 | 2024 | 284 | 0.190 |
Why?
|
| Neuroprotective Agents | 1 | 2021 | 125 | 0.180 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 87 | 0.180 |
Why?
|
| RNA | 1 | 2021 | 202 | 0.180 |
Why?
|
| Brain | 2 | 2018 | 1387 | 0.180 |
Why?
|
| Protein Transport | 1 | 2019 | 195 | 0.170 |
Why?
|
| Enzyme Activation | 1 | 2019 | 329 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2019 | 95 | 0.170 |
Why?
|
| Protein Unfolding | 1 | 2018 | 5 | 0.170 |
Why?
|
| Somatomedins | 1 | 2018 | 29 | 0.170 |
Why?
|
| Structure-Activity Relationship | 4 | 2021 | 423 | 0.170 |
Why?
|
| Tetrazoles | 1 | 2018 | 43 | 0.170 |
Why?
|
| Hippocampus | 2 | 2021 | 242 | 0.170 |
Why?
|
| Mutation | 3 | 2023 | 1501 | 0.160 |
Why?
|
| Nucleotide Motifs | 1 | 2017 | 29 | 0.160 |
Why?
|
| Triazoles | 1 | 2018 | 120 | 0.160 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 1550 | 0.150 |
Why?
|
| Membrane Proteins | 2 | 2018 | 389 | 0.150 |
Why?
|
| DNA | 1 | 2021 | 581 | 0.150 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.150 |
Why?
|
| Computational Biology | 1 | 2018 | 231 | 0.140 |
Why?
|
| Muscles | 1 | 2016 | 114 | 0.140 |
Why?
|
| Benzylidene Compounds | 1 | 2016 | 4 | 0.140 |
Why?
|
| Mitochondria | 1 | 2020 | 489 | 0.140 |
Why?
|
| Aspirin | 1 | 2017 | 127 | 0.140 |
Why?
|
| Insulin | 1 | 2018 | 510 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1663 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 153 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 866 | 0.130 |
Why?
|
| Molecular Structure | 3 | 2021 | 319 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2021 | 1096 | 0.120 |
Why?
|
| Amyloid beta-Peptides | 3 | 2021 | 82 | 0.120 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 110 | 0.120 |
Why?
|
| Computer Simulation | 3 | 2018 | 332 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 125 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 1476 | 0.100 |
Why?
|
| RNA Interference | 3 | 2016 | 195 | 0.100 |
Why?
|
| Aging | 1 | 2016 | 784 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 1202 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2021 | 142 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 642 | 0.090 |
Why?
|
| Thermodynamics | 2 | 2021 | 43 | 0.090 |
Why?
|
| Peptide Fragments | 2 | 2021 | 242 | 0.080 |
Why?
|
| Aged | 2 | 2019 | 10054 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2020 | 275 | 0.070 |
Why?
|
| Cell Death | 2 | 2016 | 223 | 0.060 |
Why?
|
| Proteomics | 2 | 2018 | 343 | 0.060 |
Why?
|
| Male | 3 | 2019 | 27334 | 0.060 |
Why?
|
| Female | 3 | 2020 | 28441 | 0.060 |
Why?
|
| Guanosine Triphosphate | 1 | 2023 | 23 | 0.060 |
Why?
|
| Tubulin | 1 | 2023 | 28 | 0.060 |
Why?
|
| Microtubules | 1 | 2023 | 57 | 0.060 |
Why?
|
| Electrophorus | 1 | 2021 | 5 | 0.050 |
Why?
|
| Butyrylcholinesterase | 1 | 2021 | 8 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2021 | 21 | 0.050 |
Why?
|
| Transcription Factor RelA | 1 | 2021 | 30 | 0.050 |
Why?
|
| Lactones | 1 | 2021 | 27 | 0.050 |
Why?
|
| Horses | 1 | 2021 | 51 | 0.050 |
Why?
|
| Protein Folding | 1 | 2021 | 52 | 0.050 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2020 | 14 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2021 | 141 | 0.050 |
Why?
|
| Glioma | 1 | 2021 | 78 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 79 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 1639 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 136 | 0.050 |
Why?
|
| Xenopus laevis | 1 | 2019 | 49 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2020 | 95 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 99 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 178 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 271 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 52 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2018 | 45 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 388 | 0.040 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 42 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 41 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2020 | 508 | 0.040 |
Why?
|
| Drug Design | 1 | 2018 | 133 | 0.040 |
Why?
|
| Actins | 1 | 2018 | 132 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 14 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 462 | 0.040 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 8 | 0.040 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2017 | 74 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2017 | 88 | 0.040 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 42 | 0.040 |
Why?
|
| Gene Expression | 1 | 2020 | 664 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 99 | 0.040 |
Why?
|
| Peptides | 1 | 2018 | 276 | 0.040 |
Why?
|
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.040 |
Why?
|
| Detergents | 1 | 2016 | 17 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2018 | 359 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 656 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2016 | 29 | 0.040 |
Why?
|
| tau Proteins | 1 | 2016 | 30 | 0.040 |
Why?
|
| Solubility | 1 | 2016 | 75 | 0.040 |
Why?
|
| Genotype | 1 | 2017 | 599 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 230 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 142 | 0.030 |
Why?
|
| Lipids | 1 | 2016 | 178 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 219 | 0.030 |
Why?
|
| Fertility | 1 | 2014 | 33 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 141 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 54 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 14207 | 0.030 |
Why?
|
| Disease Progression | 1 | 2017 | 913 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 676 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2017 | 1202 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2014 | 683 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1228 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1248 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 3431 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 4318 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 13088 | 0.010 |
Why?
|